Concepedia

Author

B J Starman

University of Washington

Also Known As

B J Starman, B Starman, B.J. Starman, BarbraJ. Starman

13

Publications

946

Citations

12

H-Index

35

Concepts

All Affiliations

University of Washington
BJ

About

B J Starman is an author at University of Washington specializing in medicine, developmental biology, and extracellular matrix.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

330

2

Cell Biology

7

7

311

3

Natural Sciences

6

6

233

4

Cellular Physiology

3

3

186

5

Biochemistry

2

2

58

B J Starman

×

12

Publications

946

Citations

12

H-Index

YearCitations

Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.

Peter H. Byers, Petros Tsipouras, Jeffrey Bonadio,

PubMed

1988

231

Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1).

Daniel H. Cohn, B J Starman, Bruce Blumberg,

PubMed

1990

168

Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta.

Richard Wenstrup, Marcia Willing, B J Starman,

PubMed

1990

116

Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.

Gillian A. Wallis, B J Starman, Arthur B. Zinn,

PubMed

1990

101

Heterozygosity for a large deletion in the alpha 2(I) collagen gene has a dramatic effect on type I collagen secretion and produces perinatal lethal osteogenesis imperfecta.

Marcia Willing, Daniel H. Cohn, B J Starman,

Journal of Biological Chemistry

1988

82

Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype.

B J Starman, David R. Eyre, Harry Charbonneau,

Journal of Clinical Investigation

1989

78

A novel mutation causes a perinatal lethal form of osteogenesis imperfecta. An insertion in one alpha 1(I) collagen allele (COL1A1).

Peter H. Byers, B J Starman, Daniel H. Cohn,

Journal of Biological Chemistry

1988

48

Substitution of cysteine for glycine within the carboxyl-terminal telopeptide of the alpha 1 chain of type I collagen produces mild osteogenesis imperfecta.

Daniel H. Cohn, Stephen Apone, David R. Eyre,

Journal of Biological Chemistry

1988

39

Substitution of arginine for glycine at position 847 in the triple-helical domain of the alpha 1 (I) chain of type I collagen produces lethal osteogenesis imperfecta. Molecules that contain one or two abnormal chains differ in stability and secretion.

Gillian A. Wallis, B J Starman, Marianne Schwartz,

Journal of Biological Chemistry

1990

26

A tripeptide deletion in the triple-helical domain of the pro alpha 1(I) chain of type I procollagen in a patient with lethal osteogenesis imperfecta does not alter cleavage of the molecule by N-proteinase.

Gillian A. Wallis, Karl E. Kadler, B J Starman,

Journal of Biological Chemistry

1992

21

Page 1